Gregg Nelson(@GreggNelsonERAS) 's Twitter Profileg
Gregg Nelson

@GreggNelsonERAS

Professor Gyn Oncology, Co-Chair Enhanced Recovery Canada, Physician Lead ERAS Alberta, Harvard MPH ‘26, #SocialMediaEditor @GynOncJnls

ID:880269442000617472

linkhttp://profiles.ucalgary.ca/gregory-nelson calendar_today29-06-2017 03:39:24

3,9K Tweets

1,6K Followers

667 Following

Follow People
@GynOncJnls(@gynoncjnls) 's Twitter Profile Photo

📄 🚨 Food deserts, endometrial cancer survivors, and healthy food access: Is it equitable in rural America? – A geospatial analysis SGO IGCS ESGO OncoAlert sciencedirect.com/science/articl…

#UCAM 📄 🚨 Food deserts, endometrial cancer survivors, and healthy food access: Is it equitable in rural America? – A geospatial analysis @SGO_org @IGCSociety @ESGO_society @OncoAlert sciencedirect.com/science/articl…
account_circle
Ginger J. Gardner(@ggardnermd) 's Twitter Profile Photo

YES!! Today was Full! 💜 FWC on the Move with Pure Barre to ⬆️ awareness & research💲for Uterine cancers…AND FWC Grant Recipient trial data just FDA approved for Uterine cancer!! Let’s all Empower More Research & More Tomorrows! Gregg Nelson 2024-move4her.raiselysite.com

account_circle
Amanda Nickles Fader, MD(@amandanfader) 's Twitter Profile Photo

📰🔥HOT OF THE PRESSES 🔥 📰Today the FDA granted approval ✅for durvalumab + carbo/taxol f/b durvalumab maintenance 💉in patients w/ dMMR, advanced/recurrent endometrial cancer. Congrats 🌟to SGO member Shannon Westin, MD, MPH, FASCO, The GOG Foundation Inc. & colleagues & AstraZeneca! FdtnForWomensCancer

account_circle
@GynOncJnls(@gynoncjnls) 's Twitter Profile Photo

A paradigm shift in understanding vulvovaginal melanoma as a distinct tumor type compared with cutaneous melanoma SGO IGCS ESGO ASCO OncoAlert sciencedirect.com/science/articl…

A paradigm shift in understanding vulvovaginal melanoma as a distinct tumor type compared with cutaneous melanoma @SGO_org @IGCSociety @ESGO_society @ASCO @OncoAlert sciencedirect.com/science/articl…
account_circle
@GynOncJnls(@gynoncjnls) 's Twitter Profile Photo

Understanding the patient experience in nonsurgical management of endometrial cancer and complex atypical hyperplasia due to obesity: A qualitative analysis
SGO IGCS ESGO OncoAlert ACOG Mayo Clinic OB/GYN sciencedirect.com/science/articl…

Understanding the patient experience in nonsurgical management of endometrial cancer and complex atypical hyperplasia due to obesity: A qualitative analysis @SGO_org @IGCSociety @ESGO_society @OncoAlert @acog @MayoGynecology sciencedirect.com/science/articl…
account_circle
@GynOncJnls(@gynoncjnls) 's Twitter Profile Photo

📄 🚨 Efficacy of immune-checkpoint inhibitors combined with cytotoxic chemotherapy in advanced or recurrent endometrial cancer: A systematic review and meta-analysis SGO IGCS ESGO International Society of Gynecologic Pathologists OncoAlert sciencedirect.com/science/articl…

#UCAM 📄 🚨 Efficacy of immune-checkpoint inhibitors combined with cytotoxic chemotherapy in advanced or recurrent endometrial cancer: A systematic review and meta-analysis @SGO_org @IGCSociety @ESGO_society @ISGynP @OncoAlert sciencedirect.com/science/articl…
account_circle
@GynOncJnls(@gynoncjnls) 's Twitter Profile Photo

Feasibility and acceptability of a nurse-led telehealth📱intervention (BOLSTER) to support patients with peritoneal carcinomatosis and their caregivers: A pilot randomized clinical trial 📊SGO IGCS ESGO OncoAlert sciencedirect.com/science/articl…

Feasibility and acceptability of a nurse-led telehealth📱intervention (BOLSTER) to support patients with peritoneal carcinomatosis and their caregivers: A pilot randomized clinical trial 📊@SGO_org @IGCSociety @ESGO_society @OncoAlert sciencedirect.com/science/articl…
account_circle
SGO(@SGO_org) 's Twitter Profile Photo

Throughout , we'll feature articles published in our journal @GynOncJnls related to endometrial/uterine cancer.

From Jan. 2024: 'Estrogen replacement therapy and non-hormonal medication use among patients with uterine cancer.'

Read the full article:
ow.ly/OHmG50SamqF

Throughout #UCAM, we'll feature articles published in our journal @gynoncjnls related to endometrial/uterine cancer. From Jan. 2024: 'Estrogen replacement therapy and non-hormonal medication use among patients with uterine cancer.' Read the full article: ow.ly/OHmG50SamqF
account_circle
SGO(@SGO_org) 's Twitter Profile Photo

During Uterine Cancer Awareness Month, SGO members are encouraged to dive into the wealth of resources and content about endometrial cancer available exclusively on SGO ConnectEd.

Access this content now:
connected.sgo.org/search?text=en…

During Uterine Cancer Awareness Month, SGO members are encouraged to dive into the wealth of resources and content about endometrial cancer available exclusively on SGO ConnectEd. Access this content now: connected.sgo.org/search?text=en…
account_circle
@GynOncJnls(@gynoncjnls) 's Twitter Profile Photo

📄 🚨 Preclinical in vitro and in vivo activity of the RAF/MEK clamp avutometinib in combination with FAK inhibition in uterine carcinosarcomas
SGO IGCS ESGO International Society of Gynecologic Pathologists OncoAlert sciencedirect.com/science/articl…

account_circle
@GynOncJnls(@gynoncjnls) 's Twitter Profile Photo

Variables that impact HPV test accuracy during vaginal self collection workflow for cervical cancer screening SGO IGCS ESGO ASCCP OncoAlert sciencedirect.com/science/articl…

Variables that impact HPV test accuracy during vaginal self collection workflow for cervical cancer screening @SGO_org @IGCSociety @ESGO_society @ASCCP @OncoAlert sciencedirect.com/science/articl…
account_circle
@GynOncJnls(@gynoncjnls) 's Twitter Profile Photo

Long-term follow-up of efficacy and safety of maintenance treatment in patients with TP53wt advanced or recurrent endometrial cancer: A subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study
ASCO The GOG Foundation Inc. Karyopharm sciencedirect.com/science/articl…

Long-term follow-up of efficacy and safety of #selinexor maintenance treatment in patients with TP53wt advanced or recurrent endometrial cancer: A subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study @ASCO #ASCO24 @GOG @Karyopharm sciencedirect.com/science/articl…
account_circle
Amanda Nickles Fader, MD(@amandanfader) 's Twitter Profile Photo

As Uterine Cancer Awareness month commences, we have more work💪🏻to do than ever to ⬇️UC incidence/mortality. Dr Francoeur presents alarming‼️UCSC/NHANES data showing dramatically📈UC rates in young & URM. A huge public health problem for women. ⁦ASCO⁩ ⁦⁦SGO

As Uterine Cancer Awareness month commences, we have more work💪🏻to do than ever to ⬇️UC incidence/mortality. Dr Francoeur presents alarming‼️UCSC/NHANES data showing dramatically📈UC rates in young & URM. A huge public health problem for women. ⁦@ASCO⁩ ⁦⁦@SGO_org⁩
account_circle
SGO(@SGO_org) 's Twitter Profile Photo

June is Uterine Cancer Awareness Month, a time to unite in our efforts to educate and advocate for those affected by endometrial cancer. The collective SGO voice holds immense power, so join us this month by sharing and engaging with our platforms to multiply our impact.

June is Uterine Cancer Awareness Month, a time to unite in our efforts to educate and advocate for those affected by endometrial cancer. The collective SGO voice holds immense power, so join us this month by sharing and engaging with our platforms to multiply our impact. #UCAM
account_circle